Cost-effectiveness of Chlorthalidone, Amlodipine, and Lisinopril as First-step Treatment for Patients with Hypertension: An Analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

OBJECTIVE: To evaluate the cost-effectiveness of first-line treatments for hypertension. BACKGROUND: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) found that first-line treatment with lisinopril or amlodipine was not significantly superior to chlorthalidone...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Heidenreich, Paul A., Davis, Barry R., Cutler, Jeffrey A., Furberg, Curt D., Lairson, David R., Shlipak, Michael G., Pressel, Sara L., Nwachuku, Chuke, Goldman, Lee
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer-Verlag 2008
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2324142/
https://ncbi.nlm.nih.gov/pubmed/18228109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11606-008-0515-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak